🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| 14/12/2022 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/07/2004 | 45,47 | 45,54 | 44,38 | 44,90 | -0,95% | 2,56% | 7.113.195 |
| 30/06/2004 | 45,32 | 45,52 | 44,76 | 45,32 | +0,32% | 1,66% | 6.176.598 |
| 29/06/2004 | 44,97 | 45,55 | 44,90 | 45,18 | +0,45% | 1,46% | 4.052.721 |
| 28/06/2004 | 45,13 | 45,21 | 44,84 | 44,98 | +0,30% | 0,82% | 4.960.289 |
| 25/06/2004 | 45,73 | 45,80 | 44,85 | 44,85 | -1,90% | 2,09% | 6.978.632 |
| 24/06/2004 | 45,65 | 46,20 | 45,43 | 45,72 | +0,21% | 1,69% | 4.425.914 |
| 23/06/2004 | 45,29 | 45,71 | 44,99 | 45,62 | +0,46% | 1,58% | 6.243.041 |
| 22/06/2004 | 45,52 | 45,73 | 45,23 | 45,41 | -0,75% | 1,11% | 5.421.723 |
| 21/06/2004 | 45,90 | 46,28 | 45,73 | 45,75 | -0,85% | 1,21% | 4.344.484 |
| 18/06/2004 | 46,12 | 46,55 | 46,02 | 46,15 | +0,08% | 1,14% | 8.639.398 |
| 17/06/2004 | 45,92 | 46,26 | 45,73 | 46,11 | +0,50% | 1,16% | 4.337.672 |
| 16/06/2004 | 45,99 | 46,25 | 45,85 | 45,88 | +0,27% | 0,87% | 5.480.935 |
| 15/06/2004 | 45,18 | 45,93 | 45,04 | 45,75 | +2,24% | 1,96% | 7.871.842 |
| 14/06/2004 | 45,35 | 45,44 | 44,73 | 44,75 | -1,84% | 1,56% | 6.899.822 |
| 10/06/2004 | 45,43 | 45,61 | 45,10 | 45,59 | -0,15% | 1,13% | 4.395.102 |
| 09/06/2004 | 45,90 | 46,16 | 45,63 | 45,66 | -1,08% | 1,16% | 3.959.868 |
| 08/06/2004 | 45,61 | 46,21 | 45,61 | 46,15 | +0,67% | 1,32% | 5.060.478 |
| 07/06/2004 | 46,04 | 46,29 | 45,68 | 45,85 | -0,31% | 1,33% | 4.656.264 |
| 04/06/2004 | 45,90 | 46,18 | 45,83 | 45,99 | +0,46% | 0,77% | 4.787.369 |
| 03/06/2004 | 45,42 | 46,05 | 45,39 | 45,78 | +0,31% | 1,45% | 5.233.502 |
| 02/06/2004 | 45,79 | 46,00 | 45,41 | 45,64 | -1,10% | 1,29% | 5.014.051 |
| 01/06/2004 | 45,23 | 46,18 | 45,09 | 46,15 | +2,24% | 2,43% | 8.079.137 |
| 28/05/2004 | 45,18 | 45,56 | 45,07 | 45,13 | -0,27% | 1,10% | 4.981.982 |
| 27/05/2004 | 44,85 | 45,32 | 44,61 | 45,26 | +1,09% | 1,60% | 5.388.606 |
| 26/05/2004 | 44,61 | 44,91 | 44,46 | 44,77 | +0,19% | 1,03% | 5.740.630 |
| 25/05/2004 | 43,92 | 44,77 | 43,89 | 44,69 | +1,25% | 2,00% | 4.090.344 |
| 24/05/2004 | 44,48 | 44,58 | 43,73 | 44,13 | -0,73% | 1,91% | 3.830.440 |
| 21/05/2004 | 44,56 | 44,71 | 44,26 | 44,46 | +0,19% | 1,03% | 3.709.501 |
| 20/05/2004 | 44,26 | 44,59 | 44,08 | 44,37 | +0,13% | 1,14% | 5.495.712 |
| 19/05/2004 | 44,80 | 44,90 | 44,18 | 44,31 | -0,88% | 1,62% | 4.734.130 |